Bage hypomethylation is an early event in colon transformation and is frequent in histologically advanced adenomas

Cancers

Volumn 1, Issue 1, 2009, Pages 3-11

  Lana, Erica ^a   Brun, Marie Elisabeth ^b   Rivals, Isabelle ^c   Selves, Janick ^d   Kirzin, Sylvain ^d   Lutsyk, Andriy P ^e   Gordiyuk, Vasily V ^f   Bibeau, Frédéric ^g   Rynditch, Alla ^f   De Sario, Albertina ^a  

^a INSERM   (France)

^b INSTITUTE OF HUMAN GENETICS   (France)

^c PSL RESEARCH UNIVERSITY   (France)

^d CHU PURPAN   (France)

^e BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^f INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^g CENTRE VAL D AURELLE   (France)

Author keywords

Adenomas; BAGE; Biomarker; COBRA; Colorectal cancer; DNA hypomethylation

Indexed keywords

EID: 84904749854     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers1010003     Document Type: Article

References (21)

1. Achkar, E.; Moayyedi, P. Colorectal Cancer Screening with Fecal Occult Blood Testing (FOBT): an international perspective. Am. J. Gastroenterol. 2006, 101, 212.
2. Kinzler, K.W.; Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 1996, 87, 159–170.
3. Ruault, M.; van der Bruggen, P.; Brun, M.E.; Boyle, S.; Roizès, G.; De Sario, A. New BAGE (B melanoma antigen) genes mapping to the juxtacentromeric regions of human chromosomes 13 and 21 have a cancer/testis expression profile. Eur. J. Hum. Genet. 2000, 10, 833–840.
4. Ruault, M.; Ventura, M.; Galtier, N.; Brun, M.E.; Archidiacono, N.; Roizès, G.; De Sario, A. BAGE genes generated by juxtacentromeric reshuffling in the Hominidae lineage are under selective pressure. Genomics 2003, 81, 391–399.
5. Grunau, C.; Sanchez, C.; Ehrlich, M.; van der Bruggen, P.; Hindermann, W.; Rodriguez, C.; Krieger, S.; Dubeau, L.; Fiala, E.; De Sario, A. Frequent DNA hypomethylation of human juxtacentromeric BAGE loci in cancer. Genes Chromosomes Cancer 2005, 43, 11–24.
6. Grunau, C.; Brun, M.E.; Rivals, I.; Selves, J.; Hindermann, W.; Favre-Mercuret, M.; Granier, G.; De Sario, A. BAGE hypomethylation, a new epigenetic biomarker for colon cancer detection. Cancer Epidemiol. Biomarkers Prev. 2008, 17, 1374–1379.
7. Rivals, I.; Personnaz, L.; Taing, L.; Potier, M.C. Enrichment or depletion of a GO category within a class of genes: which test? Bioinformatics 2007, 23, 401–407.
8. Das, P.M.; Singal, R. DNA Methylation and Cancer. J. Clin. Oncol. 2004, 22, 4632–4642.
9. Hoffmann, M.J.; Schulz, W.A. Causes and consequences of DNA hypomethylation in human cancer. Biochem. Cell Biol. 2005, 83, 296–321.
10. Paluszczak, J.; Baer-Dubowska, W. Epigenetics diagnostics of cancer-the application of DNA methylation markers. J. Appl. Genet. 2006, 47, 365–375.
11. Toyota, M.; Ohe-Toyota, M.; Ahuja, N.; Issa, J.P. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc. Natl. Acad. Sci. USA 2000, 97, 710–715.
12. Grady, W.M. Epigenetic events in the colorectum and in colon cancer. Biochem. Soc. Trans. 2005, 33, 684–688.
13. Frigola, J.; Song, J.; Stirzaker, C.; Hinshelwood, R.A.; Peinado, M.A.; Clark, S.J. Epigenetic remodelling in colorectal cancer result in coordinate gene suppression across an entire chromosome band. Nat. Genet. 2006, 38, 504–506.
14. Frigola, J.; Song, J.; Stirzaker, C.; Hinshelwood, R.A.; Peinado, M.A.; Clark, S.J. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat. Genet. 2006, 38, 540–549.
15. Bariol, C.; Suter, C.; Cheong, K.; Ku, S.L.; Meagher, A.; Hawkins, N.; Ward, R. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am. J. Pathol. 2003, 162, 1043–1045.
16. Haot, J.; Jouret, A. Colonic dysplasia in polyps and flat lesions. Acta Endoscopica 2000, 30, 145–152.
17. Petko, Z.; Ghiassi, M.; Shuber, A.; Gorham, J.; Smalley, W.; Washington, M.K.; Schultenover, S.; Gautam, S.; Markowitz, S.D.; Grady, W.M. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin. Cancer Res. 2005, 11, 1203–1209.
18. Müller, H.M.; Oberwalder, M.; Fiegl, H.; Morandell, M.; Goebel, G.; Zitt, M.; Mühlthaler, M.; Ofner, D.; Margreiter, R.; Widschwendter, M. Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 2004, 363, 1283–1285.
19. Huang, Z.H.; Li, L.H.; Yang, F.; Wang, J.F. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. World J. Gastroenterol. 2007, 13, 950–954.
20. Loktionov, A. Cell exfoliation in the human colon: myth, reality and implications for colorectal cancer screening. Int. J. Cancer 2007, 120, 2281–2289.
21. Tost, J. DNA methylation: An introduction to the biology and the disease-associated changes of a promising biomarker. Methods Mol. Biol. 2009, 507, 3–20.